Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University.

Slides:



Advertisements
Similar presentations
Regulators of Cell Cycle Progression (Literature Review) Prepared by Cai Chunhui.
Advertisements

Alterations in the Cell Cycle and Gene Mutations that Cause Cancer
Cell and Molecular Biology Behrouz Mahmoudi Cell cycle 1.
P53, Apoptosis, Cancer, More Regulation G1 checkpoint Controlled by G1 Cdk-cyclin G1 cyclin levels also vary with the cell cycle Many additional levels.
P53 The Master Guardian of the Genome. p53 gene mutations in human tumors Greenblatt et al. (1995) Cancer Res. 54: %
AP Biology Regulation of Cell Division.
Cancer Genetics Is Cancer a Genetic Disease? Cancer is not a classic genetic disease, instead, Genetic background (set-up) has a definite role in cancer.
 2.e.1 – Timing and coordination of specific events are necessary for the normal development of an organism, and these events are regulated by a variety.
Lecture 11: Signalling for Life/Death 1)Describe the eukaryotic cell cycle and the purpose of checkpoints. 2)Describe the role of cyclins and cyclin-dependent.
Cell Cycle Regulation1 Cell-cycle Control & Death Chapter 18 You will not be responsible for: details of S-CdK function mechanisms of spindle assembly.
Dr MOHAMED FAKHRY MOLECULAR BASIS OF CANCER.
P53 The Master Guardian. R point Cell cycle control involves several checkpoints and checkpoint (molecular breaking) mechanisms.
1. What is the Central Dogma? 2. How does prokaryotic DNA compare to eukaryotic DNA? 3. How is DNA organized in eukaryotic cells?
34 Cancer.
Lecture 17 Regulation of the Cell Cycle and Cell Death.
Cancer and the Cell Cycle
BioSci 145A lecture 18 page 1 © copyright Bruce Blumberg All rights reserved BioSci 145A Lecture 18 - Oncogenes and Cancer Topics we will cover today.
The Cell Cycle.
Lecture 14 - The cell cycle and cell death
21 and 23 March, 2005 Chapter 15 Regulation of Cell Number: Normal and Cancer Cells Regulated and unregulated cell proliferation.
When mammalian cells are subjected to stress signals, oxygen deficiency, radiation, DNA damage, or Chemo- therapeutic drugs, p53 is activated, leading.
BB20023/0110: Cell cycle and cancer
Tumor Supressor Gene Non-functional TSG Mutations increasing risk of cancer “Loss of function” mutation Proto-oncogene Oncogene (Hyperactive or unregulated.
Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University.
Tumor genetics Minna Thullberg
Dr Mohammad S Alanazi, MSc, PhD Molecular Biology KSU Cell Cycle Control, Defects and Apoptosis 1 st Lecture.
Biosignaling Cells - receive and act on signals Signal brings about response Types of signals: Autocrine - acting on same cell that produces them Paracrine.
GENE REGULATION ch 18 CH18 Bicoid is a protein that is involved in determining the formation of the head and thorax of Drosophila.
1. p53 Structure, Function and Therapeutic Applications Provider: Dr.Davood Nourabadi(PhD,medical physiology) mdphysiology.persianblog.ir.
Cancer and the Cell Cycle. Outline of the lecture n What is cancer? n Review of the cell cycle and regulation of cell growth n Which types of genes when.
P53 Missense Mutation Cancer. Outline Disease related to p53 Role and regulation pathway Structure of p53 Missense mutation and consequences Experiment’s.
 Regulation of Cell Number and Cancer Cells Special Limited Edition Packet Tuesday, November 10,
Genetics of Cancer Genetic Mutations that Lead to Uncontrolled Cell Growth.
Cell cycle control in mammalian cell 5 ⋆ Phosphorylation of Rb protein prevents its association with E2Fs, thereby permitting E2Fs to activate transcription.
G 1 and S Phases of the Cell Cycle SIGMA-ALDRICH.
Two Levels of Enzyme Regulation
Apoptosis Yasir Waheed. The cells of a multicellular organism are members of a highly organized community. The number of cells in this community is tightly.
Benign Versus Malignant Tumors
Cancer Detection and Diagnosis Early Cancer May Not Have Any symptoms Pap Test Mammograms Blood tests Prostate-specific antigen (PSA) Carcinoembryonic.
AH Biology: Unit 1 Control of the Cell Cycle. The cell cycle: summary G1G1 G2G2 S Interphase M Cytokinesis Mitosis.
Regulation of Cell Division Coordination of cell division A multicellular organism needs to coordinate cell division across different tissues & organs.
Genetics of Cancer Genetic Mutations that Lead to Uncontrolled Cell Growth.
Lecture 10: Cell cycle Dr. Mamoun Ahram Faculty of Medicine
Cell Cycle Checkpoint.
HOW DO CHECKPOINTS WORK? Checkpoints are governed by phosphorylation activity controlled by CDK’s (cyclin dependent kinases) Checkpoints are governed.
Oncogenes Lecture 43BSCI 420,421,620Dec 13, 2002 “It ain’t over till the fat lady sings” – Joe Gibbs 1.Cancer-critical genes a. Oncogenes b. Tumor-suppressor.
Types of Genes Associated with Cancer
AP Biology Regulation of Cell Division.
1. What is the Central Dogma? 2. How does prokaryotic DNA compare to eukaryotic DNA? 3. How is DNA organized in eukaryotic cells?
Tumor-suppressor genes Tumor-suppressor genes, function like brakes, keep cell numbers down, either by inhibiting progress through.
EUKARYOTIC CELL SIGNALING VII Abnormal Signaling in Cancer Signaling to p53 Dr. Ke Shuai Office: 9-240M Factor Tel: X69168
The Problem of Cancer. What are cancer cells ? Cancerous growth involves unrestrained proliferation (malignancy) and spread (metastasis). Caused by: mutations.
Cell Growth & Division Control of Cell Cycle | Disruptions to Cell Cycle.
Chapter 9 Cell Cycle and Cancer. Figure 17-1 Molecular Biology of the Cell (© Garland Science 2008) Cell Cycle.
Cell Cycle Checkpoints The Guardian Mechanisms of
Molecular Genetics: Part 2B Regulation of metabolic pathways:
p53 function and regulation in normal cells and cancer cells
Genes and Development CVHS Chapter 16.
The Genetic Basis of Cancer
Regulation of Gene Expression
Regulation of the Cell Cycle & Cancer
Alterations in the Cell Cycle and Gene Mutations that Cause Cancer
Concept 18.5: Cancer results from genetic changes that affect cell cycle control The gene regulation systems that go wrong during cancer are the very same.
Ch. 15 Warm-Up Compare DNA methylation and histone acetylation.
Dan Gordon  Gastroenterology  Volume 114, Issue 4, (April 1998)
Regulation of Gene Expression
Extracellular Regulation of Apoptosis
M.B.Ch.B, MSC, PhD, DCH (UK), MRCPCH
Cell Division, Cell Cycle Control, and Cancer
Control of the Cell Cycle
Presentation transcript:

Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University of Pécs and at the University of Debrecen Identification number: TÁMOP /1/A

CELL CYCLE AND CANCER, P53 Zoltan Balajthy Molecular Therapies- Lecture 13 Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University of Pécs and at the University of Debrecen Identification number: TÁMOP /1/A

Topics in chapter Tumor suppressor genes, and their biochemical functions The retinoblastoma protein Primary structure of transcription factor p53 and its regulation Restoration of p53 function in tumor cells Natural Cell Death Common elements of the three forms of natural cell death Biochemical pathways of caspase activation dependent cell death Killing tumours by induction of apoptosis TÁMOP /1/A Learning objectives of chapter 12 and 13. The purpose of this chapter is to describe the processes and regulations of both cell cycle and cell death, explain the unregulated cell division, and to point out the therapeutic intervention in cancer at molecular levels.

CDK inhibitors Dihydrofolat reductase Thymidine kinase Thymidylate synthase DNA polymerase E2F: transcription factor E2F1 EGF: epidermal growth factor CDK: cyclin-dependent protein kinase Rb: retinoblastoma protein D1, A, E: Cyclin D1, A és E DNS replication machinery Start of S phase pozitív erősítés transzkripció leállítás Transcriptional Events in G1 Phase of Cell-cycle DNS replication machinery TÁMOP /1/A

Tumor Suppressor Genes, and Their Biochemical Functions NameChromosomal localizationsBiochemical function of missing protein p5317induces CDK inhibitor p21, induces GADD45 which induces DNS repair, induces apoptosis NF-117neurofibromine (activation of ras GTPase) Neurofibromatosis, type-1 WT- 1 (Wilms-tumor)11four Zn-finger transcription factor APC5induction of apoptosis, interacts with β-catenin adenoma polyposis coli P16 melanoma9inhibitor of cdk4 PTENP1 phosphatase deleted in prostate cancer BRCA117DNS repair breast cancer BRCA113DNS repair Breast cancer TÁMOP /1/A

The retinoblastoma gene 180 kb, 27 exon 4.7 kb mRNA 105 kD fehérje Deletion was observed in this gene when observed from isolated tumor cells. The frequency of deletions in this genes corresponded to the rate of occurrence of of this tumor. From neuroblastoma tumor cells only damaged or mutated forms of this gene could be isolated. Re-introducing the cloned Rb gene into the tumor cells led to their normal proliferation (loss of tumor forming Potential) The Retinoblastoma Example Some part of chromosome 13 were very often missing when it was isolated from neuroblastoma tumors. From the corresponding part in normal chromosome 13 the neuroblastoma gene could be cloned and characterized. TÁMOP /1/A

Tumor Suppressor Genes: Retinoblastoma and P53 TÁMOP /1/A

The p53 transcription factor can either induce growth arrest or apoptosis in response to a variety of cellular stresses including exposure to DNA damaging agents, hypoxia and inappropriate proliferative signals. DNA damaging agents and UV irradiation stabilize p53 through phosphorylation of p53 at its N-terminal and activate its DNA binding through dephosphorylation and acetylation of its C-terminal region. Hypoxia and hypoglycemia stabilize p53 through both phosphorylation dependent and independent mechanisms. Inappropriate oncogene stimulation leads to p53 stabilization through the p19ARF pathway. Binding of hdm2 to p53 inhibits its transactivation activity and leads to its degradation. ARF overexpression leads to p53 stabilization by binding to hdm2 and preventing the hdm2 mediated p53 inhibition and degradation. Disruption of hdm2 and p53 interactions appears to be critical for the stabilization of p53. Stabilized and activated p53 can then transactivate its target genes. Regulation Transcription Factor of p53 I. TÁMOP /1/A

Hmd2 p53 p p p p300 DNA damage ATM / ATR Chk2 Hmd2 gene expression Cell cycle arrest Cell death p53 destruction p53 stabilization and tetramerization ubiquitin Regulation Transcription Factor of p53 II. hdm2 p53 turnover in normal conditions TÁMOP /1/A

transcriptional activation domain Sequence-specific DNA-binding domain tetramerization domain CN nuclear export signal 1520 Ser Lys 372 Lys 383 Lys Hdm2 ubiquitination or p300 acetylation p53 is of central importance in the response to DNA damage and other cellular stresses, and its activation can cause the death of the cell. It is therefore subject to an unusually large array of regulatory modifications that ensure it is present and active only when necessary. Most of these modifications increase its concentration or its intrinsic gene regulatory activity, or both, when DNA damage occurs Mutation of the gene for ATM in humans results in the disease ataxia telangiectasia, which is characterized by, among other things, a greatly reduced ability to repair radiation-induced double-strand breaks – and an increased risk of developing cancer. ATM is recruited to sites of double-strand break formation, where it phosphorylates effector molecules that carry out the damage response. Primary Structure of Transcription Factor p53 p p ATM/ATR Chk2 hdm2 TÁMOP /1/A

Cell stress Oncogene activity p53 Hdm2 Arf Nutlins Prima-1 CP Cell death Growth arrest Nutlins act by blocking interaction of Mdm2 with p53, therefore prevents its destruction leading to more of the the stable form of p53 Restoration of p53 Function in Tumor Cells III. TÁMOP /1/A

Restoration of p53 Function in Tumor Cells II. TÁMOP /1/A

13.2. Natural Cell Death is a physiologic phenomenon occurring continuously in living tissues to remove cells without any function (morphogenesis, duplicate structures, sexual dimorphism), which are produced in excess (e.g. in bone marrow), which develop improperly (e.g. part of lymphocytes), which completed their function (endometrium, tissue turnover), which are potentially dangerous (e.g. autoreactive T cells, neutrophil granulocytes). Forms of natural cell death a. Programmed cell deathEmbryogenesis functional, developmental definition; predictable in space and time; requires active protein synthesis b. Specialized forms of cell death tissue-specific terminal differentiation; the death program is suspended at one point of the death pathway; the partial death forms serve specific tissue functions; requires active protein (e.g., red blood cell, platelets, lens, cornification) c. ApoptosisMorphologic definition can be induced by non-physiologic agents does not always require active protein synthesis TÁMOP /1/A

Common Elements of The Three Forms of Natural Cell Death elimination of the nucleus DNA degradation by endonucleases acting at internucleosomal sites activation and/or induction of protein cross-linker transglutaminases Activation of specific proteases there is no leakage of intracellular macromolecules effective phagocytosis with the help of integrin receptors (except cornification and lens epithelial cells) TÁMOP /1/A

Morphology of Apoptosis Separation Condensation Fragmentation Phagocytosis Lysosomal digestion Residual body ‘HISTIOCYTE’ TÁMOP /1/A

Biochemical Pathways of Caspase Activation Dependent Cell Death TÁMOP /1/A

Killing Tumours by Induction of Apoptosis Untreated controlRadiotherapy (RT)Deathl ligand (TRAIL) Radiotherapy (RT) + Death ligand (TRAIL) Apoptosis staining Hystology staining TÁMOP /1/A